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We describe a method for independently verifying the dose distributions from pre-
and post-implant brachytherapy source distributions. Monte Carlo calculations have
been performed to characterize the three-dimensional dose distribution in water
phantom from a low-energy brachytherapy source. The calculations are performed
in a voxelized, Cartesian coordinate geometry and normalized based upon a sepa-
rate Monte Carlo calculation for the seed specific air-kerma strength to produce an
absolute dose grid with units of cGy hr21 U21. The seed-specific, three-
dimensional dose grid is stored as a text file for processing using a separate visual
basic program. This program requires the coordinate positions of each seed in the
pre- or post-plan and sums the kernel file for a three-dimensional composite
dose distribution. A kernel matrix size of 81381381 with a voxel size of
1.031.031.0 mm3 was chosen as a compromise between calculation time, kernel
size, and truncation of the stored dose distribution as a function of radial distance
from the midpoint of the seed. Good agreement is achieved for a representative pre-
and post-plan comparison versus a commercial implementation of the TG-43
brachytherapy dosimetry protocol. © 2003 American College of Medical Physics.
@DOI: 10.1120/1.1534490#
PACS number~s!: 87.53.-j, 87.52.-g
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INTRODUCTION
The AAPM Task Group 43 dosimetry protocol ~TG-43! has become an accepted standard of
practice for characterizing the dosimetric properties of 125I, 103Pd, and 192Ir brachytherapy
sources.1 Per TG-43, the dose rate D(r ,u), at point (r ,u) can be written as
D˙ ~r ,u!5SKL
G~r ,u!
G~ro ,uo!
g~r !F~r ,u!, ~1!
where Sk is the air-kerma strength of the source, L is the dose rate constant, G(r ,u) is the
geometry factor, g(r) is the radial dose function, and F(r ,u) is the anisotropy function. The point
(ro51.0 cm, uo5p/2) is defined at a radial distance of 1.0 cm on the transverse bisector of the
source. A commercial treatment planning system will typically implement the TG-43 protocol
using one of three methods: point source approximation, line source approximation, or a two-
dimensional along-away table. With respect to quality assurance of a commercial brachytherapy
treatment planning algorithm, the recommendations of TG-40 and TG-64 emphasize the need for
an independent calculation prior to implantation that will verify the TG-43 calculation for at least
one location based upon the implant seed distribution.2,3 This paper provides an alternative cal-
culation method for quality assurance purposes using a Monte Carlo based, brachytherapy seed-
specific dose kernel. The dose kernel is normalized using the simulated air-kerma strength for each
seed and stored as part of a visual basic program that sums the total dose distribution from a66 1526-9914Õ2003Õ41Õ66Õ9Õ$17.00 © 2003 Am. Coll. Med. Phys. 66
67 DeMarco, Solberg, and Agazaryan: A seed specific dose kernel . . . 67collection of seeds. We present an overview of the method, including details of the kernel simu-
lation and implementation techniques used to obtain results for qualitative comparison against
those from a conventional brachytherapy treatment planning system.
METHODS
A. The Monte Carlo code
The Monte Carlo N-particle ~MCNP version 4C! code was used to calculate the three-
dimensional dose distribution from a commercial 125I brachytherapy seed. The MCNP4C Monte
Carlo code is a general-purpose code capable of simulating coupled neutron-photon-electron prob-
lems using a three-dimensional heterogeneous geometry system.4 A detailed overview of
MCNP4C low-energy photon physics interactions and cross-section modifications has been de-
scribed in a previous study.5 The standard MCNP4C cross-section library ~DLC-200! was updated
to include the photoelectric cross-sections for Z51 – 14,19,20,22,46,47 using the more recent
DLC-146 tabulation.6 All simulations were performed in the coupled photon-electron transport
mode ~mode p e!. A kerma tally was used to calculate the collision kerma rate in water and the
air-kerma rate. The MCNP *f4 tally will score the photon kerma by scoring a track-length esti-
mate of the energy fluence and multiplying this value by an energy dependent mass energy-
absorption coefficient. This tally will yield the absorbed dose assuming local energy deposition of
secondary electrons. The mass-energy absorption coefficients for this study were taken from the
calculations of Hubbell and Seltzer.7,8
B. Source model
The Syncor Pharmaseed brachytherapy source was chosen as a representative seed design for
this study. The Pharmaseed 125I seed consists of a cylindrical palladium core, 0.325 cm long
30.05 cm in diameter, onto which a 0.5 mm layer of 125I has been uniformly adsorbed. The core
is sealed within a cylindrical titanium housing 0.45 cm in length 30.08 cm in diameter. The
cylindrical portion of the titanium housing is 0.006 cm thick, with 0.05 cm thick titanium welds at
each end. The 125I decay spectra was taken from the Table of Isotopes. Popescu et al. previously
measured and calculated the TG-43 dosimetric parameters for this source,9 while DeMarco et al.
independently verified the TG-43 parameters using the MCNP4C Monte Carlo code.10
C. Seed specific absorbed dose rate kernel
The three-dimensional dose distribution in water was calculated based upon a cylindrical phan-
tom geometry of diameter 32 cm and length 32 cm. The cylindrical phantom was discretized
into 13131 mm3 voxel elements. The water collision kerma rate was tallied in a cube of
83838 cm3, producing a dose matrix of 81381381 volume elements. The air-kerma strength
was scored in a separate simulation based upon a cylindrical geometry of 0.2 cm thick30.2 cm
deep at a radial distance of 50 cm from the center of the source. The intervening medium between
the source and air-filled scoring annulus consisted of a vacuum. For the absorbed dose rate and the
air-kerma rate simulations 403106 primary particles were followed resulting in statistical uncer-
tainty of less than 0.5% at a distance of 1.0 cm in water and 50.0 cm in air, respectively. The
statistical uncertainty increases to approximately 5% at a distance of 4 cm in water. The low-
energy photon and electron cutoff energy was set to 5.0 and 1.0 keV for the water and air-kerma
simulation, respectively. Each voxel in the three-dimensional tally cube was normalized using the
calculated air-kerma strength to produce a three-dimensional normalized dose distribution with
units of cGy hr21 U21. At 1.0 cm from the transverse bisector of the Pharmaseed source the
normalized distribution predicts a value of 0.95060.005 cGy hr21 U21. This data point is equiva-
lent to the dose rate constant and is in good agreement with the value of 0.95
60.03 cGy hr21 U21 and 0.95560.005 cGy hr21 U21 calculated by Popescu et al. using theJournal of Applied Clinical Medical Physics, Vol. 4, No. 1, Winter 2003
68 DeMarco, Solberg, and Agazaryan: A seed specific dose kernel . . . 68MCPT code9 and DeMarco et al. using the MCNP4C Monte Carlo code.10 A Visual Basic program
was written to calculate realistic pre- and post-implant brachytherapy dose distributions based
upon the normalized dose kernel. The program reads a user-supplied text file containing the x , y ,
and z coordinates for each seed in the plan and creates a cumulative dose distribution by summing
the three-dimensional kernel distribution over all seed positions. In the kernel reference frame, the
(x ,y ,z) seed coordinate is assumed to lie at the center of the single seed kernel matrix. The
transverse axis of the kernel matrix corresponds to the y axis in the treatment planning reference
frame and assumes that each kernel is perfectly aligned along the superior-inferior patient direc-
tion. This is of course an idealized approximation particularly for post-implant distributions, since
FIG. 1. Single seed, absolute dose comparisons of the Monte Carlo dose kernel ~solid line! vs TG-43 point source ~dashed
line!. The absolute isodose lines correspond to the time integrated dose ~cGy! based upon an air-kerma strength of 1.0 U
per seed.Journal of Applied Clinical Medical Physics, Vol. 4, No. 1, Winter 2003
69 DeMarco, Solberg, and Agazaryan: A seed specific dose kernel . . . 69the actual seed orientation will vary based upon the experience of the radiation oncologist or
urologist. Based upon user preference the program will output any arbitrary two-dimensional cut
through the cumulative three-dimensional distribution and compare the results with the conven-
tional brachytherapy treatment planning algorithm. This particular algorithm implements the
FIG. 2. ~Color! Comparison of the 129 seed preimplant seed distribution: Monte Carlo dose kernel ~solid line! vs TG-43
point source ~dashed line!. ~a! Axial distribution through the base cut of the prostate. ~b! Coronal distribution through the
mid-gland of the prostate. ~c! Comparison of the 129 seed pre-implant seed distribution; Monte Carlo dose kernel ~solid
line! versus TG-43 point source ~dashed line!. Dose profile comparisons based upon arbitrary horizontal and vertical cuts
through the axial distribution ~a!. The dotted line corresponds to the g calculation of Low et al.11 The absolute isodose
lines correspond to the time integrated dose ~cGy! based upon an air-kerma strength of 0.43 U per seed.Journal of Applied Clinical Medical Physics, Vol. 4, No. 1, Winter 2003
70 DeMarco, Solberg, and Agazaryan: A seed specific dose kernel . . . 70TG-43 protocol using a one-dimensional anisotropy function and assumes a point-source geometry
function.
RESULTS AND DISCUSSION
Figures 1~a! and 1~b! ~axial and coronal cut, respectively! illustrate the comparison dose dis-
tribution from one Pharmaseed brachytherapy seed for the MCNP calculation versus the commer-
FIG. 2 ~Continued.!Journal of Applied Clinical Medical Physics, Vol. 4, No. 1, Winter 2003
71 DeMarco, Solberg, and Agazaryan: A seed specific dose kernel . . . 71FIG. 3. ~Color! Comparison of the 120 seed post-implant seed distribution; Monte Carlo dose kernel ~solid line! vs TG-43
point source ~dashed line!. ~a! Axial distribution through the base cut of the prostate. ~b! Coronal distribution through the
mid-gland of the prostate. ~c! Comparison of the 120 seed post-implant seed distribution; Monte Carlo dose kernel ~solid
line! versus TG-43 point source ~dashed line!. Dose profile comparisons based upon arbitrary horizontal and vertical cuts
through the axial distribution @Fig. 3~a!#. The dotted line corresponds to the g calculation of Low et al.11 The absolute
isodose lines correspond to the time integrated dose ~cGy! based upon an air-kerma strength of 0.43 U per seed.Journal of Applied Clinical Medical Physics, Vol. 4, No. 1, Winter 2003
72 DeMarco, Solberg, and Agazaryan: A seed specific dose kernel . . . 72cial TG-43 implementation. The mid-axial distribution produces good agreement between the two
methods versus the mid-coronal cut of the seed. The observed differences at the ends of the seed
in the coronal cut are due to anisotropic effects from cladding end welds. This difference is to be
expected since the conventional brachytherapy treatment planning algorithm assumes a one-
dimensional anisotropy function for the seed. Figures 2 and 3 illustrate the comparison for a 129
and 120 seed pre- and post-implant source distribution respectively. Each figure compares the
calculation methods for an axial ~a! and coronal distribution ~b!. Good qualitative agreement is
FIG. 3 ~Continued.!Journal of Applied Clinical Medical Physics, Vol. 4, No. 1, Winter 2003
73 DeMarco, Solberg, and Agazaryan: A seed specific dose kernel . . . 73achieved with the dose kernel summation versus the conventional TG-43 implementation. Figures
2~c! and 3~c! provide a quantitative evaluation based upon one-dimensional dose profiles through
the two-dimensional axial distributions. The upper and lower parts of each figure correspond to the
horizontal and vertical profiles, respectively. Good agreement is achieved with the Monte Carlo
kernel method ~dashed line! versus the TG-43 calculation ~solid line!, except in the vicinity of a
seed. The dotted line represents the g index originally proposed by Low et al. for comparing
measured versus calculated dose distributions.11 The g index represents a scaled, two-dimensional
distance between a measurement and calculation point determined in combined dose and physical
distance space. The g normalization values used for this study are based upon a maximum percent
difference of 3% and a maximum distance-to-agreement of 3 mm. The quantitative results illus-
trated in Figs. 2~c! and 3~c! indicate that the conventional treatment planning calculation and the
Monte Carlo based kernel summation agree to within 3% or 3 mm for a g-index ,1.0. For points
close to the seed the TG-43 calculation can underestimate the absolute dose rate by a factor of 2
relative to the Monte Carlo. The particular treatment planning implementation of the TG-43 point
source model limits the user to radial dose points with a minimum distance of 2 mm from the
source, while the dose calculation grid can be any arbitrary size. For the TG-43 point source
implemented in the conventional treatment planning system, and a calculation grid spacing of 1
mm, the twelve data points surrounding the point source will be assigned an identical value based
upon the calculation point at 2 mm @see Fig. 4~b!#. The Monte Carlo calculated seed kernel is
based upon a volume tally, and therefore all voxels receive a dose based upon the average photon
track length through the voxel. This also includes the five voxels with a tally volume equal to
1 mm3 minus the source segment centered within the voxel @Fig. 4~a!#.
CONCLUSION
In this work we have demonstrated a simple summation algorithm for an independent check of
pre- or post-implant brachytherapy seed distributions. A seed specific dose kernel was generated
using the MCNP Monte Carlo code and normalized based upon a separate Monte Carlo calculation
for the seed specific air-kerma strength to produce an absolute dose grid with units of
cGy hr21 U21. The seed specific kernel distribution is calculated once for each brachytherapy
seed design and can be easily distributed via removable media or stored in a central location for
download over the internet. This program requires the coordinate positions of each seed in the pre-
or post-plan and sums the kernel file for a three-dimensional composite dose distribution. Good
agreement is achieved for a representative pre- and post-plan comparison versus a commercial
implementation of the TG-43 brachytherapy dosimetry protocol based upon a qualitative compari-
son of isodose lines and the quantitative g-index. The greatest discrepancy occurs at calculation
FIG. 4. ~Color! Dose matrix overview of the TG-43 implementation as presented for this study vs the Monte Carlo dose
kernel. The Monte Carlo dose kernel ~a! is based upon a 13131 mm3 tally voxel. A generic cylindrical brachytherapy
source with the same length as the BT-125-1 source ~4.5 mm! is illustrated for scale. The conventional treatment planning
calculation matrix ~b! is based upon a TG-43 point source centered within a discrete grid of points with separation of 1
mm. The 12 open circles are assigned the same dose value based upon the value calculated at a radial distance of 2 mm
from the point source.Journal of Applied Clinical Medical Physics, Vol. 4, No. 1, Winter 2003
74 DeMarco, Solberg, and Agazaryan: A seed specific dose kernel . . . 74points very close to a seed position. The clinical TG-43 implementation used for this study is
based upon a point source and limits the user to radial dose points greater than 2 mm from the
seed. This limitation causes the TG-43 implementation to underestimate the absolute dose rate by
up to a factor of 2 relative to the Monte Carlo based summation algorithm for calculation points
corresponding to the seed coordinates. The method described could also be applied to other
brachytherapy source designs such as 192Ir with appropriate modifications to the resolution of the
dose matrix and the size of the scoring voxel.
The recommendations of Task Group 64 ~Permanent prostate seed implant brachytherapy! are
unambiguous regarding independent verification of the conventional treatment planning system for
permanent prostate brachytherapy. The task group recommends ‘‘The medical physicist shall
verify that the treatment planning system performs the correct dose summation at one or more
locations in a simple configuration of multiple seeds,’’ and ‘‘Prior to implantation, the dosimetric
plan should be checked using an independent procedure or by a second member of the physics
staff... .’’ 2 While the two-dimensional isodose comparisons illustrated in this study are not prac-
tical for routine quality assurance, the method described could easily calculate the dose at select
points within a pre- or post-implant seed distribution. Implementing this method would require
easy access to the seed specific dose kernels and the summation program; details currently under
consideration as part of a web-based distribution.
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